Lactulose Mip (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged, where intestinal bacteria ferment it into short‑chain fatty acids. This process increases the osmotic load, drawing water into the lumen to soften stools, and lowers colonic pH, converting ammonia to ammonium, which is less readily absorbed, thereby decreasing systemic ammonia levels.

The appropriate dose of Lactulose Mip is determined by the prescribing healthcare professional based on the individual’s condition, age, renal function, and response to therapy. Dosage may be adjusted to achieve the desired stool consistency or ammonia reduction, and patients should follow the prescriber’s instructions precisely.

Safety data for lactulose in pregnancy and lactation are limited. It is generally categorized as low risk because it is minimally absorbed, but the decision to use it should be made by a qualified healthcare provider after weighing potential benefits against any uncertain risks to the mother and fetus or infant.

To place an order, submit an enquiry on the Lactulose Mip product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Lactulose is an osmotic laxative that works by retaining water in the colon, whereas stimulant laxatives (e.g., bisacodyl) increase intestinal motility. Lactulose also has the unique ability to lower colonic ammonia, making it useful for hepatic encephalopathy—a benefit not shared by most other laxatives.

Lactulose Mip should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability and potency.

Lactulose Mip is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and mixed with a small amount of water or juice if desired. Patients should follow the prescriber’s instructions regarding timing, dosage, and whether it should be taken with or without food.

Serious risks include severe electrolyte disturbances such as hyponatremia, marked dehydration from excessive diarrhea, and rare allergic reactions like rash or urticaria. In patients with compromised renal function or those on diuretics, close monitoring of fluid and electrolyte balance is essential.

Lactulose Mip should be avoided in individuals with known hypersensitivity to lactulose, in patients with complete intestinal obstruction, and in those with severe acute colitis. Caution is also advised for patients with uncontrolled diabetes, renal impairment, or those taking medications that may interact significantly.